BioSpace News Archive

From breakthroughs in the prevention of post-concussion syndrome to unprecedented advances in post-stroke, traumatic brain injury and spinal cell regeneration, TransMedia Group will bring major media attention to Hyperbaric Oxygen Therapy (HBOT) and one of the fields’ greatest pioneers, Veteran Hall of Famer Raymond Cralle.

Today, the U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare Neurodegenerative Diseases (CP-RND).

Secant Group has signed an agreement with The Abigail Wexner Research Institute at Nationwide Children’s Hospital in Columbus, OH, to explore potential solutions for repairing congenital heart defects in children.

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “TELO”) is pleased to announce that the initial clinical validation stage of its ongoing clinical study for smoldering multiple myeloma (“SMM”), in collaboration with the Mayo Clinic, has completed review and analysis of its first cohort, consisting of 187 patients and has exceeded its targeted endpoints.

Olympus announced today the market launch of the Guardenia™ Contained Extraction System.

PrecisionLife Reports 14 Genes Associated with ME/CFS at the M.E. Genetics Research Summit in Edinburgh

Maryland Life Sciences, a division of the Maryland Tech Council, is pleased to announce the first slate of speakers for its 2022 Bio Innovation Conference.

Results of a recently published clinical study demonstrated that AstaPure Arava ® by Solabia- Algatech Nutrition can have a beneficial effect on the immune system and global well-being.

Lavie Bio Ltd. today announced the appointment of Guri Oron as Chief Executive Officer (“CEO”) of Lavie Bio, effective as of September 18, 2022.

OncoNano Medicine, Inc. today announced a presentation of data from its ongoing Phase 2 study of pegsitacianine at the World Molecular Imaging Congress (WMIC), occurring September 27 – October 1, 2022.